-
1
-
-
0031959859
-
Developmental toxicity of steviol, a metabolite of stevioside, in the hamster
-
Wasuntarawat C, Emcharoen P, Toskulkao C, et al. Developmental toxicity of steviol, a metabolite of stevioside, in the hamster. Drug Chem Toxicol 1998;21:207-222.
-
(1998)
Drug Chem Toxicol
, vol.21
, pp. 207-222
-
-
Wasuntarawat, C.1
Emcharoen, P.2
Toskulkao, C.3
-
2
-
-
0024545549
-
Chronic administration of aqueous extract of Stevia rebaudiana (Bert.) Bertoni in rats: Endocrine effects
-
Oliveira-Filho RM, Uehara OA, Minetti CA, Valle LB. Chronic administration of aqueous extract of Stevia rebaudiana (Bert.) Bertoni in rats: Endocrine effects. Gen Pharmacol 1989;20:187-191.
-
(1989)
Gen Pharmacol
, vol.20
, pp. 187-191
-
-
Oliveira-Filho, R.M.1
Uehara, O.A.2
Minetti, C.A.3
Valle, L.B.4
-
4
-
-
45949093346
-
A critical review of the genetic toxicity of steviol and steviol glycosides
-
Brusick DJ. A critical review of the genetic toxicity of steviol and steviol glycosides. Food Chem Toxicol 2008;46(suppl7):S83-S91.
-
(2008)
Food Chem Toxicol
, vol.46
, Issue.SUPPL.7
-
-
Brusick, D.J.1
-
5
-
-
44849131373
-
-
Canonico M, Plu-Bureau G, Lowe GDO, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausd women: Systematic review and meta-analysis. BMJ 2008;333:1227-1231.
-
Canonico M, Plu-Bureau G, Lowe GDO, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausd women: Systematic review and meta-analysis. BMJ 2008;333:1227-1231.
-
-
-
-
6
-
-
0038583811
-
The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells
-
Seeger H, Wallwiener D, Mueck AO. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Horm Metab Res 2003;35:76-80.
-
(2003)
Horm Metab Res
, vol.35
, pp. 76-80
-
-
Seeger, H.1
Wallwiener, D.2
Mueck, A.O.3
-
7
-
-
0344304696
-
Differential effects of progestogens on breast cancer cell lines
-
Franke H, Vermes I. Differential effects of progestogens on breast cancer cell lines. Maturitas 2003;46(S1):S55-S58.
-
(2003)
Maturitas
, vol.46
, Issue.S1
-
-
Franke, H.1
Vermes, I.2
-
8
-
-
33846330128
-
-
Wood CE, Register TC, Lees CJ, et al. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res Treat 2007;101:125-134.
-
Wood CE, Register TC, Lees CJ, et al. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast Cancer Res Treat 2007;101:125-134.
-
-
-
-
9
-
-
34447344849
-
Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model
-
Wood C, Sitruk-Ware R, Yun-Yen T, et al. Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model. Menopause 2007;14:639-647.
-
(2007)
Menopause
, vol.14
, pp. 639-647
-
-
Wood, C.1
Sitruk-Ware, R.2
Yun-Yen, T.3
-
10
-
-
36549076409
-
Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study
-
Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103-111.
-
(2008)
Breast Cancer Res Treat
, vol.107
, pp. 103-111
-
-
Fournier, A.1
Berrino, F.2
Clavel-Chapelon, F.3
-
11
-
-
0001657785
-
Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
-
The Writing Group for the PEPI Trial
-
The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1996;275:370-375.
-
(1996)
JAMA
, vol.275
, pp. 370-375
-
-
-
12
-
-
0038576354
-
Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausd women
-
Wren BG, Champion SM, Willetts K, et al. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausd women. Menopause 2003;10:13-18.
-
(2003)
Menopause
, vol.10
, pp. 13-18
-
-
Wren, B.G.1
Champion, S.M.2
Willetts, K.3
-
13
-
-
0032782224
-
Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss
-
Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999;94:225-228.
-
(1999)
Obstet Gynecol
, vol.94
, pp. 225-228
-
-
Leonetti, H.B.1
Longo, S.2
Anasti, J.N.3
-
14
-
-
58149109874
-
A glyconutrient sham
-
discussion 658-563
-
Schnaar RL, Freeze HH. A "glyconutrient sham." Glycobiology 2008;18: 652-657; discussion 658-563.
-
(2008)
Glycobiology
, vol.18
, pp. 652-657
-
-
Schnaar, R.L.1
Freeze, H.H.2
-
15
-
-
0028274275
-
From ill-defined exrracts to the immunomodulatory lectin: Will there be a reason for oncological application of mistletoe?
-
Gabius HJ, Gabius S, Joshi SS, et al. From ill-defined exrracts to the immunomodulatory lectin: Will there be a reason for oncological application of mistletoe? Planta Med 1994;60:2-7.
-
(1994)
Planta Med
, vol.60
, pp. 2-7
-
-
Gabius, H.J.1
Gabius, S.2
Joshi, S.S.3
-
16
-
-
0034043914
-
Immunomodulation and anti-cancer activity of polysaccharide-protein complexes
-
Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7:715-729.
-
(2000)
Curr Med Chem
, vol.7
, pp. 715-729
-
-
Ooi, V.E.1
Liu, F.2
|